We previously reported the existence of a descending multisynaptic, pituitaryindependent neural pathway between the hypothalamus and the testes in the male rat. Collectively, these results indicate that icv injected IL-1β or EtOH blunt hCG-induced T secretion through a catecholamine-mediated mechanism that does not depend on either peripherally-mediated effects or pituitary LH, and that the PVN plays a role in these effects.
INTRODUCTION
immersion in cryoprotectant (20% sucrose in PBS), brains were cut into 30 µm coronal sections, and sections containing the PVN were processed for (NE) and tyrosine hydroxylase (TH) immunoreactivity using an NE antibody (ab8887, Abcam, UK) in a 1:4 K dilution, or a TH antibody (NB300-109, Novus Biologicals, Inc., CO) at a 1:5 K dilution using previously published immunocytochemistry techniques (15). Sections containing the PVN, which receives significant noradrenergic innervation, were examined using light microscopy, and only rats showing little or no NE immunoreactivity in this area following 6-OHDA lesions were used for statistical analysis of the data. The results of control experiments involving omission of primary antisera or secondary antisera, supported the specificity of each antiserum.
Experimental protocol
On the day of experimentation, the animals were removed to a soundproof room and housed individually in opaque buckets, with their cannulae connected by polyethylene tubings to injection sites outside the buckets, so treatments could be administered and blood withdrawn without disturbing the animals. All injections were given at least 2 h after re-housing, to allow hormone levels to return to normal. Blood samples (0.3 ml) were taken through the iv cannula and immediately replaced with an equivalent volume of apyrogenic isotonic saline.
Fluoro-Jade detection of neuronal damage
Fluoro-Jade is an anionic tribasic fluorescein derivative that stains the cell bodies, dentrites, axons and axon terminals of degenerating neurons but does not stain healthy neurons, myelin, vascular elements or neuropil (16, 17) . Following icv EtOH or vehicle (sterile water) administration, brain sections were examined following Fluoro-Jade staining by light microscope, using a 450-490 nm excitation filter. Flouro-Jade is an anionic tribasic fluorescein derivative that stains the cell bodies, dentrites, axons and axon terminals of degenerating neurons but does not stain healthy neurons, myelin, vascular elements or neuropil (16, 17) .
Measurement of testicular blood flow
We used Laser-Doppler flowmetry because this technique does not require the extensive surgery necessary in other methods and can be performed under mild anesthesia (18). This type of flowmetry yields measurements that are proportional to amount of blood flow, not the rate of flow or blood pressure (19) , and has been used to monitor testicular microvascular flow under a variety of experimental manipulations (20, 21) . Rats were anesthetized with isoflurane and core temperature was maintained at 37 o C using a circulating heating pad. The level of anesthesia was held constant by keeping the breath/minute rate between 35-40. Following opening of the scrotum, the left testicle was exposed, and a laser Doppler probe (0.85-mm diameter), attached to a blood perfusion monitor (model 403A, TSI, St. Paul, MN), was placed on two areas of the testes where there were no obvious surface blood vessels. During the experiment,
Assays
Blood alcohol levels (BALs) were measured in 5 µl plasma using an Analox AM 1 analyzer (Analox Instruments LTD, Lunenburg, MA) (23). Plasma T levels were measured in 50 µl unextracted plasma samples with a commercially available, solidphase radioimmunoassay kit (Diagnostic Products Corporation, Los Angeles, CA) (3).
Plasma LH levels were measured in 50 µl unextracted plasma samples with RIA reagents provided by the National Pituitary and Hormone Distribution Program of NIDDK (24).
PVN monoamine levels
Animals were decapitated and the whole brains were quickly removed, quick-frozen with cold isopentane in dry ice and stored at -70°C until assayed. The hypothalamus was isolated using the landmarks of the optic chiasm on the ventral surface and the fornices for the dorsal and lateral boundaries, and the PVN areas were collected using 2-mm diameter neuropunches (Fine Science Tools Inc., Foster City, CA). Monoamine measurement by HPLC was based on previously published methodology (25).
Brain preparation for in situ hybridization
Rats were deeply anesthetized with chloral hydrate, a drug that does not increase immediate early genes/peptides mRNA levels (Lee and Rivier, unpublished). They were then perfused as described above. Brains were removed and post-fixed in 4% paraformaldehyde for 4-5 days, then placed overnight in 10% sucrose/4% paraformaldehyde/0.1 M borate buffer. They were cut into 30 µm coronal slices obtained at 120 µm intervals throughout the hypothalamus, and stored at -20°C in a cryoprotectant solution (50% 0.1 M phosphate-buffered saline, 30% ethylene glycol and 20% glycerol) until histochemical analysis. Brains from control and experimental animals belonging to the same experiment were always analyzed in the same hybridization experiment. Hybridization histochemical localization of the immediate early gene (IEG) c-fos was carried out with [α]-35 S-labeled cRNA probe prepared as previously described (26, 27) . A sense probe was used as a control for non-specific signal in some adjacent sections for in situ hybridization.
Quantitative analysis of in situ hybridization results
Semiquantitative densitometric analysis of hybridization signals was carried out in nuclear emulsion-dipped slides, as previously described (27). Brain paste standards containing serial dilutions of 35 S-UTP, used for quantification of mRNA signal, were prepared concurrently to ensure that optical density was found within the linear range of the standard curve (28). Analyses with emulsion-coated slides were carried out with 2-3 different exposure times in order to confirm that signals were not saturated. 
Statistical analysis
Depending on what we estimated to convey the clearest information, data are presented as either the sum of T levels measured in 3 or more samples taken up to 90 min after hCG, or as T released as a function of time. Results were first analyzed using ANOVA with repeated measures, followed by comparison of individual time points employing Student's t test or Bonferroni/Dunn. In all cases, a difference was considered statistically significant if it reached the P<0.05 level.
RESULTS
increase blood pressure in the general circulation (33), icv injected IL-1β caused no detectable influence on testicular microvasculature flow (Fig. 3B) . When compared to data presented in Fig. 3A , icv IL-1β did not significantly alter the effect of hCG (1 U/kg) on blood flow. The icv injection of EtOH modestly but significantly (P<0.01) increased basal blood flow. It also slightly decreased the stimulatory effect of hCG (1 U/kg), though the overall difference did not reach statistical significance.
Effect of the icv injection of EtOH on LH release.
We first determined the ability of icv-injected EtOH to alter LH release in testes-intact rats. These experiments failed to indicate significant changes in LH levels, compared to those of rats injected with the vehicle (sum of LH levels measured 15, 30, 60 and 90 min after icv treatments: vehicle = 0.22 + 0.03 ng/ml; EtOH = 0.21 + 0.04 ng/ml; P>0.05).
However, we considered the possibility that the low basal LH levels measured in this model, which fall in the far left part of the RIA curve, might have masked significant changes. We therefore repeated this study in castrated rats, and found that they similarly did not respond to icv-injected EtOH with significant changes in LH concentrations (sum of LH levels measured 15, 30, 60 and 90 min after icv treatments: vehicle = 28.16 + 1.93 ng/ml; EtOH = 26.95 + 1.76 ng/ml; P>0.05).
Role of LH in the EtOH-induced inhibition of T response.
We had previously reported that the ability of IL-1β and CRF, injected icv, to interfere with hCG-induced T release was not impaired by removal of endogenous LH, which suggested that this pituitary hormone was not involved. We used a similar approach in the present work to ensure that even though EtOH did not alter mean LH levels, possible changes in the pulsatile pattern of secretion of this hormone which would not be reflected by decreased mean concentrations, did not mediate the inhibitory influence of EtOH. We therefore compared the effect of the icv injection of EtOH on hCG-induced T secretion in rats that had been pretreated with the vehicle or Azaline B 15 min earlier.
As in the case of IL-1β and CRF (5) Consequence of PVN lesions (PVNx) on the T response to icv injected EtOH or IL-1β.
As in our previous studies and according to criteria generally accepted in the literature (4, 34, 35), we chose >75% destruction of the PVN as the criterion for inclusion of an animal in the analysis of the data. We had previously reported that PVN lesions reversed the inhibitory effect of icv-injected CRF or the β-adrenergic agonist isoproterenol on the T response to hCG (4). We therefore investigated the ability of these lesions to interfere with the influence of EtOH, and compared these results with those of rats injected with IL-1β. We found that as we had previously shown (4), these lesions did not in themselves significantly alter the T response to hCG. Thus, we combined results measured in sham-operated and PVN lesioned rats injected with the vehicle icv prior to hCG. The icv injection of EtOH or IL-1β significantly (P<0.01) blunted T levels in sham-operated animals (Fig. 5) . PVN lesions totally blocked the ability of IL-1β to inhibit hCG-induced T but only partially restored this response to icv EtOH.
Effect of the icv injection of EtOH on PVN monoamine levels.
The icv injection of EtOH did not significantly alter PVN levels of any of the monoamines or their metabolites, measured 30 min later (Table 1) . IL-1β and CRF were studied for the sake of comparison. CRF significantly increased DOPAC levels versus vehicle, and both CRF and IL-1β increased catecholamine turnover as measured by the DOPAC/DA ratio. Finally, IL-1β significantly decreased PVN 5-HT vs. EtOH or CRF, and CRF increased 5-HT in comparison to vehicle.
Consequence of 6-OHDA lesions on the T response to icv-injected EtOH.
Since we had previously shown that β-adrenergic agonists stimulated the brain-testes pathway under investigation (4, 7), the ability of both icv EtOH and IL-1β to decrease hCG-induced T in rats injected with the catecholamine neurotoxin 6-OHDA was tested.
Immunohistochemistry indicated a significant decrease (>90%) in amine levels in the hypothalamus of rats with 6-OHDA lesions (not shown), which corresponds to data based on microdialysis measurement of these secretagogues (14). Because depletion of noradrenergic stores in testicular nerve endings decreases LH receptors (36), and because icv-injected compounds can leak to the periphery (37), we first verified that 6-OHDA administration into the brain ventricles was compatible with normal Leydig cell activity. As shown in Fig. 6 , lesioned rats exhibited dose-related increases in T levels and the effect of 1 U/kg hCG (the dose we routinely use in all our experiments) was virtually identical to that of sham-operated animals. We then examined the influence of 6-OHDA lesions on T release following the icv injection of EtOH and IL-1β. Both EtOH and IL-1β blunted the stimulatory effect of hCG, and 6-OHDA lesions significantly reversed the influence of both in sham versus lesioned animals receiving the same icv treatment (Fig. 7) . In the case of EtOH, the reversal was such that T levels returned to the same level as shams receiving vehicle, but in animals receiving IL-1β, T levels were significantly reversed in animals with 6-OHDA lesions, but remained well below sham/vehicle levels.
DISCUSSION
It is well known that agents such as EtOH and cytokines inhibit testicular activity through mechanisms that, depending on the route of administration and doses injected, involve blockade of LHRH/LH secretion (38), a direct influence on the gonad (39), and/or the stimulation of a catecholaminergic-dependent neural pathway (40). As discussed previously {see (1, 41, 42 )}, many stressors induce the release of factors into the circulation such as endogenous opiate-like substances and pro-inflammatory cytokines, which directly inhibit Leydig cell function. Consequently, these models cannot be used to test the modulating influence of a neural hypothalamic-testicular pathway because at least part of their ability to decrease T levels is expected to depend on a direct testicular influence of blood-borne signals. In contrast to many peripherallyadministered compounds, EtOH readily diffuses to areas protected by the blood-brain barrier, where it reaches levels that are in equilibrium with those measured in the periphery (9-11). Thus, we reasoned that injecting EtOH into the brain ventricles should mimic the CNS effects of its systemic administration while avoiding consequences due to circulating levels of the drug. We show here that the icv injection of EtOH significantly interfered with hCG-induced T secretion. Importantly, this was not accompanied by neuronal damage and did not involve the LHRH-LH axis.
Our previous studies had indicated that the PVN was an important component of the proposed efferent neural pathway between the brain and the testes (3, 4). In the present work, we used c-fos expression to determine whether the icv injection of EtOH upregulated neuronal activity in this nucleus, and showed that this was the case. These results are in keeping with the known stimulatory effect of peripherally injected alcohol on CRF and vasopressin cell bodies in the PVN (43). However, many signals exert a similar influence, and this does not necessarily reflect a functional role of the PVN in mediating their biological effects. We therefore examined the consequence of PVN lesions in rats injected with EtOH or IL-1β icv. In contrast to the obligatory role of this nucleus in modulating the ability of icv CRF or isoproterenol to blunt hCG-induced T release (4), destruction of the PVN only partially restored normal Leydig cell activity in rats administered EtOH into the brain ventricles. On the other hand, it completely abolished the effect of icv IL-1β on hCG-induced T. As we showed that EtOH did not leak to the periphery, it is highly unlikely that a direct influence of the drug on the testes, which would obviously not involve the PVN, may have played a role. Combined with the HPLC data presented here, which showed that IL-1β and CRF, but not EtOH significantly increased PVN DA turnover, our results suggest that other, presumably downstream, brain regions may also participate in the influence of EtOH, whereas IL-1β and CRF appear to work at or upstream of the PVN in this pathway.
As it is well known that the systemic administration of EtOH increases brain levels of these amines {see (44)}, we considered the possibility that icv injected EtOH might act through a mechanism that involved catecholamines present within and outside the PVN. We therefore considered the possibility that one of the mechanisms through which this drug interfered with testicular function included stimulation of the catecholamine-dependent, brain testicular pathway. Although significant changes in the levels of hypothalamic (nor)epinephrine, dopamine, serotonin or their metabolites over the time-course (30 min) separating the injection of EtOH were not detected here, it must be noted that this represents a shorter period than that usually reported to be necessary for the effect of EtOH itself (45, 46) or other signals such as cytokines on catecholamine production {see (47, 48)}. Thus, the data shown here corresponds to the lack of effect of peripherally injected EtOH on brain levels of DOPAC and serotonin over the short time frame that was necessary for the effect of alcohol. On the other hand, we observed small but significant changes in IL-1β or CRF-induced [DOPAC/DA] ratio in the PVN, an indicator of DA turnover. It remains, of course, possible that by taking tissues 30 min after icv treatments, we missed physiologically relevant changes in catcholamines levels that might have been present at other times. In this context, we therefore need to emphasize two points. First, the time point we chose was based on preliminary data indicating that it represented peak responses in terms of IL-1β and CRF. Second, the time course over which changes in catecholamines levels are relevant is the one that corresponds to significant effects of icv-injected treatments on T release.
Consequently, if such changes occurred at later times, i.e., those more closely related to the data available in the published literature (47, 48), it is difficult to understand how they could be functionally relevant in our model. The only other potentially interesting changes would therefore be those taking place before the 30 min we used in our studies.
A final possibility is that catecholamine levels were altered in brain regions that we did not investigate. Of relevance for this hypothesis is our recent finding that indeed, the icv injection of alcohol induces significant changes in catecholamines levels in the locus coeruleus, and that these changes may be functionally relevant for the ability of the drug to alter Leydig cell activity (Selvage and Rivier, in preparation).
While these hypotheses are presently under study, we decided to use another approach to probe the role of catecholamines in rats injected icv with EtOH or IL-1β.
Specifically, we injected the neurotoxin 6-OHDA to deplete amine levels in the hypothalamus. In view of the importance of the splanchnic innervation of the testes in the integrity of LH receptors (7, 49), it was important to first ascertain that this experimental manipulation did not alter the T response to hCG. We show here that depletion of brain catecholamine content was compatible with normal Leydig cell activity. In contrast, 6-OHDA lesions significantly reversed the inhibitory effect of both icv EtOH and IL-1β when comparing sham versus 6-OHDA lesioned animals receiving these treatments. This observation corresponds to our previous report that the icv injection of β-adrenergic antagonists significantly but not completely reversed the influence of IL-1β and CRF on Leydig cell function (7). In view of the results illustrated in Table 1 and Fig. 7 , future experiments will be necessary to examine the respective roles of dopamine, epinephrine and norepinephrine in mediating the influence of icvinjected EtOH. One argument that has been repeatedly raised to explain at least part of the inhibitory influence of icv-injected IL-1β and CRF on Leydig cell activity, is that these treatments might decrease blood flow to and/or from the testes. If present, this phenomenon would decrease the amount of hCG delivered to Leydig cells and/or impair T release from the testes. In the past, we presented much indirect evidence that argued against this hypothesis. First, it is well known that the icv injection of CRF increases blood pressure in the general circulation {see (50)}, and more recent evidence has indicated a similar phenomenon in rats receiving . These responses seemed difficult to reconcile with decreased blood flow at the testicular level. Second, various models of immune stimulation, including those accompanied by elevated levels of pro-inflammatory cytokines such as IL-1β, are also accompanied by upregulated blood pressure (51). Third, the finding of specific inhibition of the StAR protein but not other testicular enzymes, the absence of histological evidence for impaired testicular vascularization and the persistence of diminished T response to hCG ex vivo (52), had provided what we considered solid support against impaired testicular blood flow as a mechanism responsible for the inhibitory effect of IL-1β and CRF on Leydig cell activity.
Finally, the concept of a functional relationship between decreased T release and altered blood delivery to the testes is not supported by the fact that low T levels induced by sepsis, for example, are accompanied by a significant increase in testicular blood flow (51). Nevertheless, repeated encounters with the argument that icv treatments impaired Leydig cell activity by acting on the testicular microvasculature, prompted us to specifically monitor its parameters by Laser-Doppler flowmetry under a variety of conditions. We found that, as suggested by the work listed above, changes in peripheral blood pressure are not necessarily valid predictors of altered testicular blood flow. For example, we observed that the peripheral administration of CRF, which is known to lower blood pressure in the general circulation {see (53)} did not significantly influence testicular capillary flow (Selvage, unpublished). However, it was found that the topical administration of phenylephrine gel rapidly and significantly decreased testicular blood flow, an observation that is in agreement with results obtained after the intratesticular injection of epinephrine (20). We then turned to hCG, which had been reported to cause delayed and prolonged effects on the testicular microvasculature after sc administration of very large doses (30) (31) (32) 54) . We report here that even a small amount of this gonadotropin was able to increase blood flow and that this effect, while transient, was very rapid. In contrast, neither EtOH nor IL-1β had a marked influence. Collectively, these results suggest that the ability of icv treatments to interfere with T release in response to hCG, is unlikely to be mediated by impaired activity of the testicular microvasculature.
In conclusion, we have developed a unique model of stress that avoids the confounding influence of peripheral effects due to blood-borne secretagogues.
Specifically, we have shown that the direct injection of a small amount of EtOH into the brain ventricles was capable of rapidly blunting Leydig cell activity independently of altered LH secretion and decreased testicular blood flow. Even though the hypothalamic PVN participates in this antireproductive effect, other brain regions and/or mechanisms are likely to play a role, as indicated by the only partial ability of PVN lesions to restore full T secretion following icv EtOH, but fully restored the ability of IL-1β to do so. Moreover, we show the importance of an intact catecholaminergic system for the effects of icv IL-1β and EtOH on T synthesis and secretion, and further delineate the agents (i.e., IL-1β and CRF) which act at or upstream of the PVN in the pathway under investigation, versus those (EtOH) which act both at, and downstream, of the PVN. Also, while the inhibitory effect of systemic EtOH on T release is well documented, this is the first demonstration that this drug can modify Leydig cell activity strictly through a CNS site of action. These results suggest that the early phase of the T response to peripheral EtOH administration, which is often not accompanied by decreased LH release and probably precedes steroidogenic defects resulting from circulating levels of the drug, may involve this neural circuit. Until now, the difficulty in isolating the sites of action of EtOH, which include the LHRH-LH axis, a direct influence on testicular steroidogenesis due to circulating amounts of the drug, and a neural hypothalamic-testicular pathway, have hindered the development of treatments aimed at preventing or reversing its detrimental effects on sex steroid production. A better understanding of the importance of a neural pathway mediating the inhibitory influence of EtOH, IL-1β and other stress-linked agents on androgen secretion, may provide such palliative or restorative therapies for pathologies associated with impaired testicular function that do not depend on abnormal pituitary activity, and therefore cannot be addressed with supplemental gonadotropin. 
